Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

The Relationship Between Individual Characteristics and Interest in Using a Mobile Phone App for HIV Self-Management: Observational Cohort Study of People Living With HIV.

Lucero RJ, Frimpong JA, Fehlberg EA, Bjarnadottir RI, Weaver MT, Cook C, Modave F, Rathore MH, Morano JP, Ibanez G, Cook RL.

JMIR Mhealth Uhealth. 2017 Jul 27;5(7):e100. doi: 10.2196/mhealth.7853.

2.

Antiretroviral therapy outcomes among HIV infected clients in Gweru City, Zimbabwe 2006 - 2011: a cohort analysis.

Shambira G, Gombe NT, Hall CD, Park MM, Frimpong JA.

Pan Afr Med J. 2017 May 28;27(Suppl 1):13. doi: 10.11604/pamj.supp.2017.27.1.12562. eCollection 2017.

3.

Conducting a surveillance problem analysis on poor feedback from Reference Laboratory, Liberia, February 2016.

Frimpong JA, Amo-Addae MP, Adewuyi PA, Hall CD, Park MM, Nagbe TK.

Pan Afr Med J. 2017 May 28;27(Suppl 1):11. doi: 10.11604/pamj.supp.2017.27.1.12569. eCollection 2017.

4.

Detecting, reporting, and analysis of priority diseases for routine public health surveillance in Liberia.

Frimpong JA, Amo-Addae MP, Adewuyi PA, Hall CD, Park MM, Nagbe TK.

Pan Afr Med J. 2017 May 28;27(Suppl 1):10. doi: 10.11604/pamj.supp.2017.27.1.12561. eCollection 2017.

5.

Detecting, reporting, and analysis of priority diseases for routine public health surveillance in Liberia.

Frimpong JA, Park MM, Amo-Addae MP, Adewuyi PA, Nagbe TK.

Pan Afr Med J. 2017 May 28;27(Suppl 1):9. doi: 10.11604/pamj.supp.2017.27.1.12570. eCollection 2017.

6.

An epidemic of spastic paraparesis of unknown aetiology in Northern Mozambique.

Taibo CLA, Cliff J, Rosling H, Hall CD, Park MM, Frimpong JA.

Pan Afr Med J. 2017 May 28;27(Suppl 1):6. doi: 10.11604/pamj.supp.2017.27.1.12623. eCollection 2017.

7.

Investigating an outbreak of measles in Margibi County, Liberia, October 2015.

Frimpong JA, Amo-Addae MP, Adewuyi PA, Park MM, Hall CD, Nagbe TK.

Pan Afr Med J. 2017 May 28;27(Suppl 1):5. doi: 10.11604/pamj.supp.2017.27.1.12564. eCollection 2017.

8.

Corrigendum to "Evidence-based treatment for opioid disorders: A 23-year national study of methadone dose levels" [Journal of Substance Abuse Treatment 47 (2014) 245-250].

D'Aunno T, Pollack HA, Frimpong JA, Wutchiett D.

J Subst Abuse Treat. 2017 Aug;79:75. doi: 10.1016/j.jsat.2017.05.001. Epub 2017 Jun 10. No abstract available.

PMID:
28673531
9.

Incidence of medically attended influenza among residents of Shai-Osudoku and Ningo-Prampram Districts, Ghana, May 2013 - April 2015.

Ntiri MP, Duque J, McMorrow ML, Frimpong JA, Parbie P, Badji E, Nzussouo NT, Benson EM, Adjabeng M, Dueger E, Widdowson MA, Dawood FS, Koram K, Ampofo W.

BMC Infect Dis. 2016 Dec 13;16(1):757.

10.

The Role of Program Directors in Treatment Practices: The Case of Methadone Dose Patterns in U.S. Outpatient Opioid Agonist Treatment Programs.

Frimpong JA, Shiu-Yee K, D'Aunno T.

Health Serv Res. 2017 Oct;52(5):1881-1907. doi: 10.1111/1475-6773.12558. Epub 2016 Sep 12.

PMID:
27618580
11.

Spillover effects of HIV testing policies: changes in HIV testing guidelines and HCV testing practices in drug treatment programs in the United States.

Frimpong JA, D'Aunno T, Helleringer S, Metsch LR.

BMC Public Health. 2016 Jul 29;16:666. doi: 10.1186/s12889-016-3322-4.

12.

Hepatitis C testing in substance use disorder treatment: the role of program managers in adoption of testing services.

Frimpong JA, D'Aunno T.

Subst Abuse Treat Prev Policy. 2016 Apr 1;11:13. doi: 10.1186/s13011-016-0057-2.

13.

On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial.

Frimpong JA, D'Aunno T, Perlman DC, Strauss SM, Mallow A, Hernandez D, Schackman BR, Feaster DJ, Metsch LR.

Trials. 2016 Mar 3;17(1):117. doi: 10.1186/s13063-016-1225-4.

14.

Abstinence at Successful Discharge in Publicly Funded Addiction Health Services.

Frimpong JA, Guerrero EG, Kong Y, Kim T.

J Behav Health Serv Res. 2016 Oct;43(4):661-675.

PMID:
26882909
15.

Low Rates of Adoption and Implementation of Rapid HIV Testing in Substance Use Disorder Treatment Programs.

Frimpong JA, D'Aunno T, Helleringer S, Metsch LR.

J Subst Abuse Treat. 2016 Apr;63:46-53. doi: 10.1016/j.jsat.2015.12.001. Epub 2015 Dec 28.

16.

Correlates of HIV testing and receipt of test results in addiction health services in Los Angeles County.

Frimpong JA, Guerrero EG, Kong Y, Tsai G.

Subst Abuse Treat Prev Policy. 2015 Aug 7;10:31. doi: 10.1186/s13011-015-0026-1.

17.

HIV Testing, Care, and Treatment Among Women Who Use Drugs From a Global Perspective: Progress and Challenges.

Metsch L, Philbin MM, Parish C, Shiu K, Frimpong JA, Giang le M.

J Acquir Immune Defic Syndr. 2015 Jun 1;69 Suppl 2:S162-8. doi: 10.1097/QAI.0000000000000660. Review.

18.

Evidence-based treatment for opioid disorders: a 23-year national study of methadone dose levels.

D'Aunno T, Pollack HA, Frimpong JA, Wuchiett D.

J Subst Abuse Treat. 2014 Oct;47(4):245-50. doi: 10.1016/j.jsat.2014.06.001. Epub 2014 Jun 10.

19.

Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study.

Frimpong JA, D'Aunno T, Jiang L.

Am J Public Health. 2014 Jun;104(6):e75-82. doi: 10.2105/AJPH.2013.301827. Epub 2014 Apr 17.

20.

The complex association of health insurance and maternal health services in the context of a premium exemption for pregnant women: a case study in Northern Ghana.

Frimpong JA, Helleringer S, Awoonor-Williams JK, Aguilar T, Phillips JF, Yeji F.

Health Policy Plan. 2014 Dec;29(8):1043-53. doi: 10.1093/heapol/czt086. Epub 2013 Nov 20.

PMID:
24262280

Supplemental Content

Loading ...
Support Center